2015年至2024年结直肠癌的新辅助疗法:视觉分析和文献计量分析
Boyu Kang1, Yihuan Qiao1, Jun Zhu1,2
1Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, China.
Frontiers in oncology
|April 17, 2025
概括
本文献测量分析绘制了结直肠癌 (CRC) 新辅助疗法的研究趋势. 关键的新兴领域包括人工智能,全新辅助疗法和免疫疗法,指导未来的研究方向.
科学领域:
- 在瘤学瘤学.
- 图书统计学 图书统计学
- 医疗信息学 医疗信息学
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的全球健康挑战.
- 目前的研究趋势和CRC新辅助疗法的热点需要澄清.
研究的目的:
- 创建CRC新辅助疗法研究的视觉知识地图.
- 识别关键的研究热点,并使用文献识别分析预测未来的趋势.
主要方法:
- 从Web of Science核心集合 (2015-2024) 中对1587篇文章进行了图书统计分析.
- 使用Bibliometrix R,CiteSpace和VOSviewer进行数据可视化和分析.
- 审查的作者,机构,国家,期刊和关键词.
主要成果:
- 中国在出版物 (449) 中领先,而美国在平均引用量 (21.6) 中领先.
- "外科瘤学年鉴"和"临床瘤学杂志"是著名的期刊.
- 新兴的关键词包括"人工智能"",全新辅助疗法"和"免疫疗法".
结论:
- 本综述为未来的结直肠癌新辅助疗法研究提供了参考.
- 这些发现为CRC治疗的进步方向提供了有价值的见解.
关键词:
图书馆指数 (Bibliometrix) 是一个指数.在CiteSpace中使用CiteSpace.在VOSviewer中使用VOSviewer.结肠直肠癌是什么意思新辅助疗法是一种新辅助疗法.更多相关视频
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
56
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Cancer Survival Analysis
300
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
300
